Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen-specific cellular immune responses.
Woodchucks infected with the woodchuck hepatitis virus (WHV) is the best available animal model for testing the immunotherapeutic effects of dendritic cells (DCs) in the setting of a chronic infection, as woodchucks develop a persistent infection resembling that seen in humans infected with the hepatitis B virus. In the present study, DCs were generated from woodchuck peripheral blood mononuclear cells (wDCs) in the presence of human granulocyte macrophage colony-stimulating factor (hGM-CSF) and human interleukin 4 (hIL-4). After 7 days of culture, cells with morphology similar to DCs were stained positively with a cross-reactive anti-human CD86 antibody. Functional analysis showed that uptake of FITC-dextran by wDCs was very efficient and was partially inhibited after LPS-induced maturation. Furthermore, wDCs stimulated allogenic lymphocytes and induced proliferation. Moreover, wDCs were transduced efficiently with a human adenovirus serotype 5 for the expression of beta-galactosidase. Following transduction and in vivo administration of such DCs into woodchucks, an antigen-specific cellular immune response was induced. These results demonstrate that wDCs can be generated from the peripheral blood. Following transfection with a recombinant adenovirus wDCs can be used as a feasible and effective tool for eliciting WHV-specific T-cell responses indicating their potential to serve as prophylactic and therapeutic vaccines.
Ochoa-Callejero
Laura
L
Laboratory of Gene Therapy of Viral Hepatitis, Division of Gene Therapy and Hepatology, Center for Applied Medical Research (CIMA), Pamplona, Navarra, Spain.
Berraondo
Pedro
P
Crettaz
Julien
J
Olagüe
Cristina
C
Vales
Africa
A
Ruiz
Juan
J
Prieto
Jesús
J
Tennant
Bud C
BC
Menne
Stephan
S
González-Aseguinolaza
Gloria
G
D000256:Adenoviridae / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D051940:B7-2 Antigen / Q000276:immunology / Q000378:metabolism; D002455:Cell Division; D002478:Cells, Cultured; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D004195:Disease Models, Animal; D005822:Genetic Vectors; D019694:Hepatitis B, Chronic / Q000276:immunology / Q000628:therapy; D006801:Humans; D007111:Immunity, Cellular; D007114:Immunization; D007115:Immunization Schedule; D007167:Immunotherapy / Q000379:methods*; D007279:Injections, Subcutaneous; D008214:Lymphocytes / Q000276:immunology; D008392:Marmota / Q000276:immunology; D016865:Reassortant Viruses / Q000276:immunology; D013045:Species Specificity; D014161:Transduction, Genetic; D001616:beta-Galactosidase / Q000096:biosynthesis / Q000276:immunology
D051940:B7-2 Antigen; D001616:beta-Galactosidase